Trials / Unknown
UnknownNCT03370575
RCT of Ethiodized Poppyseed Oil VS the Second-generation Non-ionic Monomer Contrast in Hysterosalpingography of Infertile Patients.
A Randomized, the Second-generation Non-ionic Monomer Contrast Parallel Control, Multicenter Clinical Study to Evaluate the Imaging Diagnostic Quality and Fertility Promoting Effect of Ethiodized Poppyseed Oil in Hysterosalpingography of Infertile Patients.
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 900 (estimated)
- Sponsor
- Guangzhou Women and Children's Medical Center · Academic / Other
- Sex
- Female
- Age
- 21 Years – 39 Years
- Healthy volunteers
- Not accepted
Summary
This study evaluates the difference of imaging diagnostic quality and fertility promoting effect in the diagnosis and treatment of infertility by hysterosalpingography between using ethiodized poppyseed oil and the second-generation non-ionic monomer contrast. Half of participants will receive ethiodized poppyseed oil for hysterosalpingography, while the other half will receive the second-generation non-ionic monomer contrast for hysterosalpingography.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ethiodized poppyseed oil | Hysterosalpingography using ethiodized poppyseed oil |
| DRUG | the second-generation non-ionic monomer contrast | Hysterosalpingography using the second-generation non-ionic monomer contrast |
Timeline
- Start date
- 2018-01-31
- Primary completion
- 2019-05-01
- Completion
- 2020-05-01
- First posted
- 2017-12-12
- Last updated
- 2018-07-05
Locations
13 sites across 1 country: China
Source: ClinicalTrials.gov record NCT03370575. Inclusion in this directory is not an endorsement.